Compare NeoGenomics Inc. Common Stock (NEO) vs Personalis Inc. Common Stock (PSNL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NeoGenomics Inc. Common Stock vs Personalis Inc. Common Stock — how do they compare? NeoGenomics Inc. Common Stock trades at $17 (market cap $2.17B), while Personalis Inc. Common Stock trades at $15.75 (market cap $1.70B). The key difference: NeoGenomics Inc. Common Stock is the larger of the two by market cap, and Personalis Inc. Common Stock is more actively traded (3,262,398 versus 1,615,943). Which is the better fit depends on your goals — on Pluang, investors hold NeoGenomics Inc. Common Stock for 0 Days and Personalis Inc. Common Stock for 0 Days on average.
| NEO | PSNL | |
|---|---|---|
Market Cap | $2.17B | $1.70B |
Volume | 1,615,943 | 3,262,398 |
Sector | Health | Health |
52-Week High | $19.91 | $18.38 |
52-Week Low | $7.19 | $5.04 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.47B | $1.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About NeoGenomics Inc. Common Stock
NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →About Personalis Inc. Common Stock
Personalis Inc. is a cancer genomics company that provides tumor- and blood-based DNA and RNA sequencing tests, including its NeXT Personal liquid biopsy test for cancer monitoring.
Read more on PSNL →
